Molecular docking cannot accurately predict drug off-target effects: implications for the role of voriconazole in the exacerbation of myasthenia gravis
- PMID: 24127354
- DOI: 10.1002/mus.24089
Molecular docking cannot accurately predict drug off-target effects: implications for the role of voriconazole in the exacerbation of myasthenia gravis
Comment in
-
Author reply: To PMID 23666793.Muscle Nerve. 2014 Jan;49(1):148. doi: 10.1002/mus.24084. Epub 2013 Nov 22. Muscle Nerve. 2014. PMID: 24123082 No abstract available.
-
A rare side effect due to voriconazole: myasthenia gravis.Eur J Clin Pharmacol. 2022 Aug;78(8):1357-1359. doi: 10.1007/s00228-022-03349-4. Epub 2022 Jun 3. Eur J Clin Pharmacol. 2022. PMID: 35657415 No abstract available.
Comment on
-
Exacerbation of myasthenia gravis with voriconazole.Muscle Nerve. 2013 Jun;47(6):928-30. doi: 10.1002/mus.23751. Epub 2013 May 11. Muscle Nerve. 2013. PMID: 23666793
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
